Efstratios Gavriilidis
Overview
Explore the profile of Efstratios Gavriilidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kogias D, Gavriilidis E, Antoniadou C, Skeva A, Kafalis N, Tsilingiris D, et al.
J Viral Hepat
. 2025 Feb;
32(3):e70005.
PMID: 39927678
Hepatitis E virus (HEV) infection is a frequent cause of acute viral hepatitis. Immunocompromised patients, especially those under anti-CD20 regimens, are prone to chronic or treatment-resistant courses of hepatitis E....
2.
Antoniadou C, Gavriilidis E, Ritis K, Tsilingiris D
Metabol Open
. 2025 Jan;
25:100344.
PMID: 39886103
Anemia is a frequent, yet increasingly recognized, comorbidity in diabetes mellitus (DM), with prevalence often driven by multifactorial mechanisms. Hematinic deficiencies, common in this population, may arise from associated comorbidities...
3.
Gavriilidis E, Divolis G, Natsi A, Kafalis N, Kogias D, Antoniadou C, et al.
Front Immunol
. 2024 Sep;
15:1447608.
PMID: 39346917
Introduction: Crohn's disease (CD) is characterized by chronic inflammation and intestinal fibrosis leading to lifelong complications. However, the disease pathogenesis remains elusive, and the therapeutic options are limited. Here, we...
4.
Natsi A, Gavriilidis E, Antoniadou C, Papadimitriou E, Papadopoulos V, Tsironidou V, et al.
J Intern Med
. 2024 Jul;
296(4):379.
PMID: 38975637
No abstract available.
5.
Natsi A, Gavriilidis E, Antoniadou C, Papadimitriou E, Papadopoulos V, Tsironidou V, et al.
J Intern Med
. 2024 May;
296(3):298-301.
PMID: 38805484
No abstract available.
6.
Gavriilidis P, Askari A, Gavriilidis E, Di Saverio S, Davies R, DeAngelis N
Ann Transl Med
. 2023 Sep;
11(10):373.
PMID: 37675324
No abstract available.
7.
Gavriilidis P, Askari A, Gavriilidis E, Di Saverio S, Davies R, DeAngelis N
Ann Transl Med
. 2023 Apr;
11(6):265.
PMID: 37082684
Background: Haemorrhoids are a very common disease and many professional societies have produced guidelines for their treatment. The aim of this study is to appraise the quality of the existing...
8.
Chrysanthopoulou A, Antoniadou C, Natsi A, Gavriilidis E, Papadopoulos V, Xingi E, et al.
Clin Immunol
. 2023 Jan;
247:109240.
PMID: 36693535
Kruppel-like factor 2 (KLF2) has been linked with fibrosis and neutrophil-associated thromboinflammation; however, its role in COVID-19 remains elusive. We investigated the effect of disease microenvironment on the fibrotic potential...
9.
Skendros P, Germanidis G, Mastellos D, Antoniadou C, Gavriilidis E, Kalopitas G, et al.
Sci Adv
. 2022 Aug;
8(33):eabo2341.
PMID: 35977025
Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first randomized trial evaluating a C3...
10.
Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, et al.
Clin Immunol
. 2022 Apr;
238:109016.
PMID: 35447311
Aiming to reduce mortality in COVID-19 with severe respiratory failure we administered a combined rescue treatment (COMBI) on top of standard-of-care (SOC: dexamethasone/heparin) consisted of inhaled DNase to dissolve thrombogenic...